Keyphrases
Alzheimer's Disease Treatment
100%
Tau Pathology
100%
Alzheimer's Disease
70%
Autophagy
60%
Neurodegenerative Diseases
58%
Neuroinflammation
50%
Chaperone-mediated Autophagy
50%
Bromo
50%
Transcription Factor EB
50%
Phosphorylated tau
50%
Dopaminergic Neurons
50%
Parkinson's Disease Model
50%
Protopine
50%
Celastrol
50%
Isocorynoxeine
50%
Inducing Autophagy
50%
Rotenone
50%
Bacterial Extracellular Vesicles
50%
Parkinson's Disease
40%
Tau Aggregates
33%
Autophagy Enhancers
28%
Histone Deacetylase 6 (HDAC6)
25%
Small Molecules
22%
Alpha-synuclein (α-syn)
20%
Neuroprotective Effect
20%
P301S
16%
Anti-tau
16%
Alzheimer's Disease Model
16%
Lysosomal Biogenesis
16%
Animal Disease Models
16%
Brain Permeability
16%
Therapeutic Agents
14%
Rapamycin
10%
Neuronal Loss
10%
Mechanistic Target
10%
Chinese Herbal Medicine
10%
Systemic Administration
10%
Tyrosine Hydroxylase
10%
Ultra-low Dose
10%
Potential Drugs
10%
Substantia Nigra Pars Compacta
10%
Small Molecular
10%
Motor Dysfunction
10%
Drug Candidates
10%
Delivery System
10%
Oxindole Alkaloids
10%
Uncaria Rhynchophylla
10%
Induced Models
10%
3xTg-AD Mice
8%
Cognitive Loss
8%
HDAC6 Inhibitor
8%
IC50 Value
8%
Memory Function
8%
Tripterygium Wilfordii
8%
Tau Mouse Model
8%
Hsc70
8%
Fold Increase
8%
Pathological tau
8%
Root Extract
8%
Active Ingredients
8%
Master Regulator
8%
Molecular Docking
8%
Alkaloids
8%
Memory Loss
8%
Gong
8%
3xTg-AD
8%
Effective Therapy
8%
Autophagosome
8%
G-value
8%
Neuronal Cell Lines
8%
Anti-Alzheimer Drugs
8%
Mouse Brain
8%
Tauopathy
8%
Therapeutic Strategies
8%
Memory Impairment
8%
Molecular Chaperone
8%
Safe Therapy
8%
Protein Aggregates
8%
Tau Degradation
8%
Alzheimer's Disease Patient
8%
Parent Compounds
8%
LAMP2
8%
Pharmacological Activities
8%
Novel Agents
8%
Cognitive Deficits
8%
Intracellular Interactions
6%
Neuroimmune Response
6%
Antibody Protein
6%
Risk Factors
6%
Monoclonal Antibody
6%
Blood-brain Barrier
6%
New Therapeutic Strategies
6%
Small Interfering RNA (siRNA)
6%
Offensive
6%
Plasmid
6%
Protein Molecules
6%
Cargo
6%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
62%
Nervous System Inflammation
50%
Degenerative Disease
50%
Dopamine Receptor Stimulating Agent
50%
Parkinson's Disease
50%
Rotenone
50%
Protopine
50%
Combination Therapy
50%
Histone Deacetylase 6
25%
Synuclein
14%
Neuroprotective Agent
14%
Disease Model
12%
Rapamycin
7%
Systemic Administration
7%
Tyrosine 3 Monooxygenase
7%
Motor Dysfunction
7%
Uncaria rhynchophylla
7%
Oxindole
7%
Small Interfering RNA
6%
Monoclonal Antibody
6%
Amnesia
6%
Blood-Brain Barrier
6%
Immunoglobulin
6%
Chaperone
6%
IC50
6%
Mouse Model
6%
Disease Activity
6%
Drug Action
6%
Biochemistry, Genetics and Molecular Biology
Tau
100%
Transcription Factor
50%
Chaperone-Mediated Autophagy
50%
Autophagy
50%
HDAC6
18%
Tripterygium wilfordii
14%
Biogenesis
14%
Animal Disease Model
14%
Small Molecule
11%
Enhancer Region
7%
3XTg Mouse
7%